Form 4: Royalty Pharma Director Bonnie L. Bassler Receives Stock Award

Bonnie L. Bassler, a director at Royalty Pharma plc, received an award of 7,614 Class A Ordinary Shares on May 13, 2025.

Summary

• On May 13, 2025, Bonnie L. Bassler, a director of Royalty Pharma plc, was granted 7,614 Class A Ordinary Shares.
• The shares were awarded under the Issuer's 2020 Independent Director Equity Incentive Plan.
• These restricted stock units are scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date.
• Following the transaction, Ms. Bassler directly owns 70,054 Class A Ordinary Shares.

Sentiment

Score: 7

Explanation: The document reflects a standard director compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The stock award aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company.

Future Outlook

The vesting of the restricted stock units is contingent upon the terms of the 2020 Independent Director Equity Incentive Plan and the applicable award agreement.

Industry Context

Stock awards to directors are a common practice to incentivize and align their interests with the long-term performance of the company. This is a standard component of executive compensation packages in publicly traded companies.

Stakeholder Impact

• The stock award aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The vesting schedule encourages the director's continued service and contribution to the company.

Key Dates

Keywords

Royalty Pharma, Director, Stock Award, Beneficial Ownership, RPRX, Form 4, Equity Incentive Plan, Restricted Stock Units